SeaStar Medical Holding Corporation ICU
3.42
(0.02)
(0.58%)
as of 25 Sep
- Market cap
- $15.2M
- P/E
- 0.0×
Follow ICU
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (356.87%) | (302.01%) | (295.15%) | (290.37%) |
+8 more TTM periods Free account |
|
| (160.02%) | (126.18%) | (129.15%) | (135.86%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(351.66%) | (174.57%) | (123.50%) | (126.43%) | |
Average Days of Receivables |
44.32 | 45.50 | 70.10 | 91.56 | |
Free Cash Flow per Share |
(3.35) | (3.50) | (6.56) | (5.38) | |
Free Cash Flow |
(13.69) | (13.71) | (13.60) | (14.20) | |
Piotroski F-Score |
3.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Cash ROIC |
(121.66%) | (82.25%) | (60.72%) | (56.28%) | |
Accounts Receivable Turnover |
8.06 | 9.94 | 7.07 | 6.10 | |
Accounts Payable Turnover |
0.06 | 0.05 | 0.00 | 0.00 | |
Inventory Turnover |
1.64 | 1.96 | — | — | |
Average Days of Payables |
2,172.62 | 2,650.86 | 0.00 | 0.00 | |
Days of Inventory on Hand |
223.06 | 210.15 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
520.37% | 517.48% | 609.24% | 914.42% | |
Selling, General and Administrative Expense of Revenue |
389.03% | 408.22% | 473.10% | 761.41% | |
Share Based Compensation of Revenue |
20.55% | 58.91% | 74.72% | 120.77% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.00 | 1.15 | 1.12 | 1.04 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.42 | 0.37 | 0.60 | 0.33 | |
Operating CF per Share |
(3.35) | (3.50) | (6.56) | (5.38) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(795.50%) | (828.62%) | (984.60%) | (1,551.08%) |
Columns are period end dates